(S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide, 95.0%, 250mg

Isonicotinohydrazide, 95.0%, 100g

(R)-2,2,2-Trifluoro-1-phenylethylaminehydrochloride, 95.0%, 100mg

2,6-Dichloro-4-(trifluoromethyl)nicotinic acid, 95.0%, 5g

6-cyclopropyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 98%, 1g

Filtration unit with cellulose nitrate membrane Pore size 0.2 μm, without grid, 500 ml, 1000 ml, 75 mm, 12 Piece(s)

1-(3-BETA-AMINO-2,3-DIDEOXY-BETA-D-THREOPENTA-FURANOSYL)THYMINE, 95.0%, 100mg

4,9-Dibromonaphtho[2,3-c][1,2,5]selenadiazole, 95%, 1g

(2E)-1-(2-methoxyphenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

4,5-Dimethoxy-1-cyanobenzocyclobutane, 95.0%, 10g

4-FLUORO-1H-INDAZOLE-5-CARBOXYLIC ACID, 95%, 500mg

3-Bromo-8-chloro-1,5-naphthyridine, 95.0%, 10g

2-Chlorothiazolo[4,5-b]pyrazine, 95%, 5g